Why Egg Number Is Only One Part of an IVF Discussion About Low Ovarian Reserve

If an ovarian reserve test has come back low, the first number you hear can feel like the whole story. It is not. Ovarian reserve describes an estimate of how many eggs remain in the ovaries. It does not measure the quality of any single egg, and it does not tell you what will happen in one particular IVF cycle. Egg number is one input among several, and the weight it deserves depends on your age, your history, your partner’s or donor’s sperm findings, and what you are actually trying to achieve.

What ovarian reserve tests actually measure

Tests such as anti-Müllerian hormone (AMH), antral follicle count (AFC) on ultrasound and follicle-stimulating hormone (FSH) are used to estimate ovarian reserve. They are population-level estimates: they describe a range, not a precise inventory. AMH and FSH can vary between cycles and between laboratories, and AFC depends partly on who performs and reads the scan. A single result is a snapshot, and repeating a test does not necessarily give a truer picture.

What these tests are reasonably good at is helping a clinician anticipate how you might respond to ovarian stimulation and discuss starting doses or protocol options. What they cannot do is predict the quality of the eggs you do produce, whether a given egg will fertilise, or whether a resulting embryo will have a normal chromosome number. Those are separate questions, and each has its own uncertainty.

Quantity and quality are different questions

A low reserve mainly raises the possibility of a smaller number of eggs collected in a cycle. It does not mean those eggs are poor. Egg quality is influenced strongly by age, and it varies from egg to egg even within the same cycle. This is why two people with similar AMH values can have very different experiences, and why a clinician will usually weigh your age and prior response alongside the test result rather than reading the number in isolation.

It also helps to separate the stages between an egg and a transfer. A retrieved egg must be mature, fertilise, develop into a blastocyst, and — if testing is planned — survive biopsy and produce a usable result. Each stage can reduce the number available at the next. A low starting count therefore does not translate neatly into a low final count, and a higher count does not guarantee a larger number of embryos suitable for transfer.

Where PGT fits, and where it does not

Preimplantation genetic testing is sometimes raised in low-reserve conversations, but it is not automatically part of every plan. PGT-A assesses chromosome number in cells sampled from an embryo; it has limitations and can produce incorrect findings, and a result does not guarantee a successful pregnancy or a healthy child. PGT-M concerns a known single-gene condition, and PGT-SR concerns chromosomal structural rearrangements — different questions from PGT-A. Whether any of these tests is appropriate depends on your history and should be discussed with your treating team and a genetic counsellor where relevant.

With a small number of embryos, the practical value of testing becomes a genuine trade-off rather than a default. Biopsy itself carries a risk of damage that can prevent further development, and a mosaic result is inferred from intermediate findings in a sample — it does not establish the cell composition of the whole embryo. These are reasons to ask how a result would change your decisions before committing to testing, not reasons to rule it out. For background on reading a PGT-A quotation, see PGT-A testing cost in Thailand.

What else changes how a number should be weighed

• Age: the same AMH means something different at 32 and at 42, because age shifts the expected proportion of eggs with normal chromosomes.
• Prior stimulation response: how you responded before is often more informative for planning than a test alone.
• Sperm findings: semen analysis results affect fertilisation and embryo development independently of your reserve. Reading count, movement and morphology together is more useful than any single value — see reading a semen analysis as one picture.
• Uterine and other findings: the lining and cavity matter to implantation regardless of how many eggs were collected.
• Your goals: an own-egg attempt, openness to donor eggs, timeline, cost tolerance and willingness to repeat cycles all change what a given number implies for you.

That last point is not a soft consideration. Two patients with identical results can reasonably make different choices, because the question is not only “how many eggs” but “how many cycles, at what cost, with which alternatives, and on what timeline.” If a first cycle yields few mature eggs, it is worth reviewing what happened before deciding what to change — see low egg yield or few mature eggs in one cycle.

A worked planning example

Suppose a 38-year-old patient has a low AMH and is considering treatment in Thailand. A useful planning conversation would not stop at the number. It would cover: what her prior response suggests about stimulation; whether a modest egg yield makes PGT-A a reasonable trade-off or an unnecessary step; how many cycles she is prepared to consider; whether donor eggs should be discussed now rather than after several attempts; and what her timeline allows for travel. None of those answers comes from the AMH value alone, and none should be settled before a clinician reviews her records. For the travel-specific version of this discussion, see IVF in Thailand with diminished ovarian reserve.

Questions worth putting to your treating doctor

• Which reserve tests were used, and how much variation should I expect if they are repeated?
• Given my age and any prior response, what range of egg numbers would you consider plausible for me?
• How would a low yield change your recommendation on stimulation protocol?
• Would PGT-A change anything in my plan, and what would we do differently depending on the result?
• At what point should we discuss alternatives, including donor eggs, and what would that involve?
• What records from my home clinic would help you assess this properly?

Interpretation of your results and any treatment recommendation belongs to your treating clinician. A coordinator can help you gather records, prepare a question list and request an appointment or remote consultation, but cannot diagnose or prescribe. If you are comparing quotations, check what each includes before drawing conclusions — itemised price inclusions in Thai IVF explains what to verify.

The short version

Ovarian reserve estimates quantity, with real variability. Egg quality, fertilisation, embryo development and chromosome status are separate questions with their own uncertainty. PGT is one option among several, not a requirement, and its value depends on how a result would change your decisions. Your age, history, sperm findings and individual goals all shape what a given egg number means. Treat the number as the opening of the conversation, not its conclusion.